2 Cases Remanded To State Court From GSK Avandia MDL

Law360, New York (April 06, 2012, 1:37 PM ET) -- A federal judge on Wednesday sent two cases back to state court from a multidistrict litigation against GlaxoSmithKline PLC for alleged Medicaid fraud related to its diabetes drug Avandia, saying there weren't enough significant federal issues to justify keeping the cases in federal court.

GSK had argued against remanding the cases, saying that they involve embedded federal questions because the states' obligation to pay for Avandia is rooted in the federal Medicaid statutes, and deciding whether the company misrepresented Avandia requires interpretation of decisions by the...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

IN RE: AVANDIA MARKETING, SALES PRACTICES AND PRODUCTS LIABILITY LITIGATION


Case Number

2:07-md-01871

Court

Pennsylvania Eastern

Nature of Suit

P.I.: Personal Inj. Prod. Liability

Judge

CYNTHIA M. RUFE

Date Filed

October 18, 2007

Law Firms

Companies

Government Agencies